Previous studies have shown that CCL20-CCR6 plays an important role in a variety of autoimmune diseases, such as RA, IBD, and other diseases, and the level of CCL20 is associated with disease severity [33], as well as in EAU [34]. This evidence concerns the gene CCR6 and inflammatory bowel disease.